Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
April 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 |
May 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |||
| 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | 30 | 31 |
June 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 |
Press releases published on April 14, 2025
Chasin A Dream Foundation Launches Mindful Haven to Support Families of Children with Life-Threatening Illnesses
EIN Presswire
·
April 14, 2025
The Jupiter based 501(c)(3) foundation has launched a program specifically designed to support the parents, siblings, and caregivers of warrior children. JUPITER, FL, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- Chasin A Dream Foundation is proud …
SABER College impulsa carreras con propósito: Inscripciones abiertas para el programa de Asistente de Terapia Física
EIN Presswire
·
April 14, 2025
Estudia PTA en SABER College y transforma tu futuro. Programa en inglés, inicio 28 de abril. Ayuda financiera disponible para quienes califiquen. MIAMI, FL, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- SABER College anuncia que están abiertas las …
Sterling Lexicon's Redesigned Website Enhances User Experience, Showcases Talent Mobility Expertise
EIN Presswire
·
April 14, 2025
New features emphasize flexible solutions to meet changing workforce mobility priorities JACKSONVILLE, FL, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- Sterling Lexicon, a global leader in workforce mobility solutions, is proud to unveil its …
Massive Bio reçoit son attestation de certification par la CNIL pour sa mise en conformité au RGPD
EIN Presswire
·
April 14, 2025
Massive Bio certifiée par la CNIL pour le traitement sécurisé des données de santé et l’appariement aux essais cliniques en France. BOCA RATON, FL, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- Massive Bio obtient son attestation de certification …
Massive Bio Receives CNIL Certification for GDPR Compliance
EIN Presswire
·
April 14, 2025
Massive Bio is now authorized to process medical records in France, marking a major step in AI-driven clinical trial matching across Europe. BOCA RATON, FL, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- Massive Bio holds certification from the …
TODAY IS CONN’S SYNDROME AWARENESS DAY; 1 IN 10 PEOPLE SUFFERING FROM HIGH BLOOD PRESSURE HAVE THIS AND DON'T KNOW
EIN Presswire
·
April 14, 2025
TAMPA, FL, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- Today is the first annual Conn’s Syndrome Awareness Day. Despite affecting nearly 1 in 10 people with high blood pressure, it remains a widely undiagnosed adrenal disorder. Dr. Carling will …
NAYA Biosciences Announces Strategic Decision to Separate Fertility and Oncology Businesses into Distinct Operations – Company Renamed “INVO Fertility, Inc.”
GlobeNewswire
·
April 14, 2025
Public company to operate under new name and concentrate on building, acquiring and operating fertility clinics and the distribution of FDA-cleared INVOcell device Private company to operate as NAYA Therapeutics and focus on clinical development of …
MediciNova To Participate in D. Boral’s Capital Global Conference on May 14, 2025
GlobeNewswire
·
April 14, 2025
LA JOLLA, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announces that their CEO, …
Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results
GlobeNewswire
·
April 14, 2025
- Appointed John H. Johnson as Executive Chairman; Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer; and Reena Thomas Colacot as Vice President and Head of Quality NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: …
BioSyent to Attend Planet MicroCap Showcase
GlobeNewswire
·
April 14, 2025
MISSISSAUGA, Ontario, April 14, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be attending the Planet MicroCap Showcase: VEGAS 2025 investor conference in Las Vegas, Nevada from April 22nd to April …
Cue Biopharma Announces Proposed Public Offering
GlobeNewswire
·
April 14, 2025
BOSTON, April 14, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of …
Cue Biopharma to Host Business Update Call and Webcast
GlobeNewswire
·
April 14, 2025
BOSTON, April 14, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of …
Aurora Spine Announces the Resignation of Board Director James Snow
GlobeNewswire
·
April 14, 2025
CARLSBAD, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that …
Boehringer Ingelheim and Cue Biopharma partner to develop next-generation treatment for autoimmune and inflammatory diseases
GlobeNewswire
·
April 14, 2025
Partnership bolsters Boehringer’s autoimmune and inflammatory disease pipeline portfolio aiming to tackle areas of high unmet patient need. The agreement focuses on further research and development of a novel, first-in-class bispecific compound for T cell …
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 14, 2025
WALTHAM, Mass., April 14, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases, today announced that it …
TOMI Environmental Solutions, Inc. Reports Fourth Quarter and Year End 2024 Financial Results
GlobeNewswire
·
April 14, 2025
FREDERICK, Md., April 14, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination utilizing its premier Binary Ionization Technology (BIT) platform through its …
Voting Rights and Shares Capital of the Company
GlobeNewswire
·
April 14, 2025
In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, April 14, 2025 (GLOBE NEWSWIRE) -- Market: Euronext Paris / Nasdaq …
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
GlobeNewswire
·
April 14, 2025
Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers PARIS, 14 avr. 2025 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Paris / Nasdaq Euronext Compartiment : B Code ISIN : …
BioStem Technologies Reports Record Preliminary Fourth-Quarter Net Revenue of $102.9 Million and Preliminary Full-Year 2024 Revenue of $301.8 Million
GlobeNewswire
·
April 14, 2025
Company reports record preliminary fourth quarter net revenue of $102.9 Million, contributing to a total of $301.8 Million in revenue for 2024 Achieves preliminary GAAP net income of $15.5 million, or $0.94 per share, marking the fourth consecutive quarter …
SI-BONE To Report First Quarter 2025 Financial Results on May 5, 2025
GlobeNewswire
·
April 14, 2025
SANTA CLARA, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will report financial results for the first quarter of 2025 after market close on …